Hodgkin Lymphoma Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Recruiting
- Acute Myeloid Leukemia
- +14 more
- Fludarabine
- +7 more
- Philadelphia, PennsylvaniaThomas Jefferson University
2022-04-07
Apr 7, 2022N
Completed
- Leukemia
- +3 more
- Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
2022-04-07
Apr 7, 2022M
Recruiting
- Hodgkin Lymphoma
- pembrolizumab
- +9 more
- Birmingham, Alabama
- +84 more
2022-04-07
Apr 7, 2022S
Recruiting
- Hodgkin Lymphoma
- +3 more
- Biostrap arm band
- Palo Alto, CaliforniaStanford University
2022-03-29
Mar 29, 2022N
Completed
- Acute Lymphoblastic Leukemia
- +5 more
- Radiation
- +3 more
- New Hyde Park, New YorkCohen Children's Medical Center
2022-04-06
Apr 6, 2022C
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial
Not yet recruiting
- Hodgkin Lymphoma
- Non-Hodgkin Lymphoma
- Exercise Intervention
- +2 more
- Duarte, CaliforniaCity of Hope Medical Center
2022-04-04
Apr 4, 2022S
Recruiting
- Hodgkin Lymphoma
- +2 more
- brentuximab vedotin
- Anaheim, California
- +18 more
2022-04-01
Apr 1, 2022S
Recruiting
- Hodgkin Lymphoma
- brentuximab vedotin
- +5 more
- Fountain Valley, California
- +72 more
2022-04-01
Apr 1, 2022T
Recruiting
- Acute Lymphoblastic Leukemia
- +15 more
- Hematopoietic Cell Transplantation
- +7 more
- Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-01
Apr 1, 2022D
Active, not recruiting
- Hodgkin Lymphoma
- +2 more
- Duarte, California
- +5 more
2022-03-28
Mar 28, 2022C
Suspended
- Mediastinal Lymphoma
- +2 more
- Standard treatment protocol with combined chemoradiation
- Taoyuan, TaiwanChang Gung Memorial Hospital
2022-03-08
Mar 8, 2022T
Recruiting
- Hodgkin Lymphoma
- No Intervention
- Wroclaw, Dolnoslskie, Poland
- +14 more
2022-03-04
Mar 4, 2022C
Recruiting
- Hodgkin Lymphoma
- Combined chemotherapy with or without involved-field radiotherapy
- Chengdu, China
- +2 more
2022-03-17
Mar 17, 2022C
Recruiting
- Hematologic Malignancies
- +16 more
- A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs)
- Birmingham, Alabama
- +138 more
2022-03-17
Mar 17, 2022M
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Total Body Irradiation
- +4 more
- New York, New YorkMemorial Sloan - Kettering Cancer Center
2022-03-16
Mar 16, 2022A
Not yet recruiting
- Hodgkin Lymphoma
- IFRT vs NFRT
- (no location specified)
2022-03-09
Mar 9, 2022F
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022H
Recruiting
- Non Hodgkin Lymphoma
- +3 more
- Tampa, FloridaMoffitt Cancer Center
2022-03-14
Mar 14, 2022T
Enrolling by invitation
- Hodgkin Lymphoma
- Lung Cancer
- Low dose CT thorax
- Manchester, United KingdomThe Christie NHS Foundation Trust
2022-03-10
Mar 10, 2022B
Recruiting
- Mantle Cell Lymphoma
- +9 more
- L-Bcl-2 antisense oligonucleotide
- Augusta, Georgia
- +2 more
2022-03-08
Mar 8, 2022N
Recruiting
- Non-hodgkin Lymphoma
- Hodgkin Lymphoma
- DOC Group B
- +16 more
- Valhalla, New YorkNew York Medical College
2022-02-23
Feb 23, 2022C
C
Recruiting
- Acute Lymphoblastic Leukemia
- +6 more
- Bioelectric Impedance Analysis
- +7 more
- Duarte, CaliforniaCity of Hope Comprehensive Cancer Center
2022-03-07
Mar 7, 2022C
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Donor Search Prognosis Score
- Duarte, California
- +51 more
2022-03-07
Mar 7, 2022M
Recruiting
- Hodgkin Lymphoma
- Relapsed or Refractory Hodgkin Lymphoma
- pembrolizumab
- +4 more
- Miami, Florida
- +8 more
2022-03-07
Mar 7, 2022